These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35352998)

  • 21.
    Sawicki R; Ginalska G
    Future Med Chem; 2019 Aug; 11(16):2193-2203. PubMed ID: 31538522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mandelic acid-based spirothiazolidinones targeting M. tuberculosis: Synthesis, in vitro and in silico investigations.
    Trawally M; Demir-Yazıcı K; Dingiş-Birgül Sİ; Kaya K; Akdemir A; Güzel-Akdemir Ö
    Bioorg Chem; 2022 Apr; 121():105688. PubMed ID: 35189443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysocin E Targeting Menaquinone in the Membrane of Mycobacterium tuberculosis Is a Promising Lead Compound for Antituberculosis Drugs.
    Geberetsadik G; Inaizumi A; Nishiyama A; Yamaguchi T; Hamamoto H; Panthee S; Tamaru A; Hayatsu M; Mizutani Y; Kaboso SA; Hakamata M; Ilinov A; Ozeki Y; Tateishi Y; Sekimizu K; Matsumoto S
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0017122. PubMed ID: 35969044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis.
    Anishetty S; Pulimi M; Pennathur G
    Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An integrated computational approach towards novel drugs discovery against polyketide synthase 13 thioesterase domain of Mycobacterium tuberculosis.
    Altharawi A; Alossaimi MA; Alanazi MM; Alqahatani SM; Tahir Ul Qamar M
    Sci Rep; 2023 Apr; 13(1):7014. PubMed ID: 37117557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting tuberculosis: a glimpse of promising drug targets.
    Arora N; Banerjee AK
    Mini Rev Med Chem; 2012 Mar; 12(3):187-201. PubMed ID: 22356190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elucidation of marine fungi derived anthraquinones as mycobacterial mycolic acid synthesis inhibitors: an in silico approach.
    Sharma A; Islam MH; Fatima N; Upadhyay TK; Khan MKA; Dwivedi UN; Sharma R
    Mol Biol Rep; 2019 Apr; 46(2):1715-1725. PubMed ID: 30715689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of
    Cardoso NC; Chibale K; Singh V
    ACS Infect Dis; 2022 Mar; 8(3):414-421. PubMed ID: 35175727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three promising antimycobacterial medicinal plants reviewed as potential sources of drug hit candidates against multidrug-resistant tuberculosis.
    Tuyiringire N; Deyno S; Weisheit A; Tolo CU; Tusubira D; Munyampundu JP; Ogwang PE; Muvunyi CM; Heyden YV
    Tuberculosis (Edinb); 2020 Sep; 124():101987. PubMed ID: 32841928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virtual Screening of Small Molecular Inhibitors against DprE1.
    Zhang G; Guo S; Cui H; Qi J
    Molecules; 2018 Feb; 23(3):. PubMed ID: 29495447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentacyclic nitrofurans with in vivo efficacy and activity against nonreplicating Mycobacterium tuberculosis.
    Rakesh ; Bruhn DF; Scherman MS; Woolhiser LK; Madhura DB; Maddox MM; Singh AP; Lee RB; Hurdle JG; McNeil MR; Lenaerts AJ; Meibohm B; Lee RE
    PLoS One; 2014; 9(2):e87909. PubMed ID: 24505329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro bactericidal activity of 3-cinnamoyl-4-hydroxy-6-methyl-2-pyrone (CHP) against drug-susceptible, drug-resistant and drug-tolerant isolates of Mycobacterium tuberculosis.
    Bhat ZS; Rather MA; Ul Lah H; Hussain A; Maqbool M; Yousuf SK; Jabeen Z; Wani MA; Ahmad Z
    J Glob Antimicrob Resist; 2020 Sep; 22():57-62. PubMed ID: 31809940
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Taira J; Ito T; Nakatani H; Umei T; Baba H; Kawashima S; Maruoka T; Komatsu H; Sakamoto H; Aoki S
    Int J Mycobacteriol; 2017; 6(2):142-148. PubMed ID: 28559515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Antimicrobials from Uncultured Bacteria Acting against Mycobacterium tuberculosis.
    Quigley J; Peoples A; Sarybaeva A; Hughes D; Ghiglieri M; Achorn C; Desrosiers A; Felix C; Liang L; Malveira S; Millett W; Nitti A; Tran B; Zullo A; Anklin C; Spoering A; Ling LL; Lewis K
    mBio; 2020 Aug; 11(4):. PubMed ID: 32753498
    [No Abstract]   [Full Text] [Related]  

  • 36. Discovery of Mycobacterium tuberculosis α-1,4-glucan branching enzyme (GlgB) inhibitors by structure- and ligand-based virtual screening.
    Dkhar HK; Gopalsamy A; Loharch S; Kaur A; Bhutani I; Saminathan K; Bhagyaraj E; Chandra V; Swaminathan K; Agrawal P; Parkesh R; Gupta P
    J Biol Chem; 2015 Jan; 290(1):76-89. PubMed ID: 25384979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approach.
    Magotra A; Sharma A; Singh S; Ojha PK; Kumar S; Bokolia N; Wazir P; Sharma S; Khan IA; Singh PP; Vishwakarma RA; Singh G; Nandi U
    Pulm Pharmacol Ther; 2018 Feb; 48():151-160. PubMed ID: 29174840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, In silico Molecular Docking and Pharmacokinetic Studies, In vitro Antimycobacterial and Antimicrobial Studies of New Imidozolones Clubbed with Thiazolidinedione.
    Khan IH; Patel NB; Patel VM
    Curr Comput Aided Drug Des; 2018; 14(4):269-283. PubMed ID: 29766819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products.
    Rodrigues Felix C; Gupta R; Geden S; Roberts J; Winder P; Pomponi SA; Diaz MC; Reed JK; Wright AE; Rohde KH
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.
    Chaudhari K; Surana S; Jain P; Patel HM
    Eur J Med Chem; 2016 Nov; 124():160-185. PubMed ID: 27569197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.